News
The federal government has only sent four shipments of Merck's Covid-19 antiviral molnupiravir (about 400,000 courses in each shipment) nationwide, and already HHS is reporting that some ...
Alex Gorsky, the CEO whose nine-year tenure at J&J was marred by lawsuits over the company's talc baby powder and opioids, will step away from his ...
B Capital, an investment firm co-founded by Eduardo Saverin of Facebook fame, has closed its inaugural healthcare fund. Add that to its capital growth fund, and B Capital says it ...
Just weeks after the FDA announced its hold on foreign inspections will continue into February, the feds' accountability office is calling upon the regulatory agency to make changes to improve ...
LinusBio, a Mount Sinai spinoff starting out focused on neurological disorders like autism, announced Thursday it raised $16 million in Series A funding. Proceeds will go toward building its ...
Reps. Kelly Armstrong (R-ND) and Ben Cline (R-VA) sent a letter last week to Attorney General Merrick Garland, asking why the Department of Justice is willing to incur potential patent ...
Covid-19 roundup: US secures 100,000 doses of Eli Lilly's antibody cocktail; Merck's $356M supply deal on hold as FDA asks for more data ...
Manufacturing roundup: WuXi STA unveils new facility; Purdue University nets $3M grant for zero-waste pharma manufacturing ...
CARGO Therapeutics will join the Nasdaq on Friday morning in what some industry insiders think could be the final, maybe penultimate, initial public offering for a biotech this year. ...
In September, Moderna received FDA emergency use authorization for its BA.4/BA.5-targeting bivalent booster vaccine, mRNA-1273.222, based on preclinical data for the shot as well as Phase II/III ...
WuXi Biologics serves up $1.4B expansion of research and manufacturing center in Singapore ...
Endpoints 11 winner Ascidian Therapeutics: A search-and-replace technology comes to RNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results